Position in VCYT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,654,709
+$1,938,110 QoQ
Shares Held
62,229
+16.8% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#101
of 365 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ZACKS INVESTMENT MANAGEMENT holds $85,439,394 across 8 Diagnostics & Research names. VCYT ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
158,423 | $30,176,413 | |
| 2 | LH |
Labcorp Holdings Inc.
|
85,568 | $23,959,040 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
43,021 | $21,569,008 | |
| 4 | ILMN |
Illumina, Inc.
|
28,137 | $4,947,328 | |
| 5 | VCYT |
Veracyte, Inc.
This page
|
62,229 | $3,654,709 | |
| 6 | MYGN |
Myriad Genetics Inc
|
81,392 | $464,748 | |
| 7 | A |
Agilent Technologies, Inc.
|
3,494 | $464,108 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,056 | $204,040 |
All Filings in VCYT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,654,709 | 62,229 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,716,599 | 53,294 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,363,325 | 56,136 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,794,806 | 52,281 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,315,982 | 48,686 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,490,386 | 50,266 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,964,080 | 49,598 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,123,149 | 32,995 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||